Adulthood nicotine treatment alleviates behavioural impairments in rats neonatally treated with quinpirole: Possible roles of acetylcholine function and neurotrophic factor expression

European Journal of Neuroscience

Volumn 19, Issue 6, 2004, Pages 1634-1642

  Brown, Russell W ^a,b   Thompson, Kenyatta D ^a   Thompson, Kimberly N ^b   Ward, J Jeffrey ^b   Thacker, Stephanie K ^a   Williams, Michael T ^c   Kostrzewa, Richard M ^b  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b East Tennessee State University   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Chat; D2 receptor; Dopamine; Morris water task; Nerve growth factor (NGF); Skilled reaching; Spatial memory

Indexed keywords

ACETYLCHOLINE; DOPAMINE 2 RECEPTOR; NEUROTROPHIC FACTOR; NICOTINE; QUINPIROLE;

ACETYLCHOLINE RELEASE; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HIPPOCAMPUS; MALE; NEUROLOGIC DISEASE; NEWBORN DISEASE; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR SENSITIVITY; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

ACETYLCHOLINE; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHOLINE O-ACETYLTRANSFERASE; COGNITION DISORDERS; DOPAMINE AGONISTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; HUMANS; MALE; NERVE GROWTH FACTOR; NICOTINE; NICOTINIC AGONISTS; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; SWIMMING; TIME FACTORS; YAWNING;

EID: 1842556147     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03199.x     Document Type: Article

References (62)

1. Abdulla, F.A., Calaminici, M.R., Stephenson, J.D. & Sinden, J.D. (1993) Chronic treatments with cholinoceptor drugs influence spatial learning in rats. Psychopharmacology (Berl.), 111, 508-511.
2. Adler, L.E., Olincy, A., Waldo, M., Harris, J.G., Griffith, J., Stevens, K., Flach, K., Nagamoto, H., Bickford, P., Leonard, S. & Freedman, R. (1998) Schizophrenia, sensory gating, and nicotinic receptors. Schizophr. Bull., 24, 189-202.
3. Anand, A., Verhoeff, P., Seneca, N., Zoghbi, S.S., Seibyl, J.P., Charney, D.S. & Innis, R.B. (2000) Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am. J. Psychiatry, 157, 1108-1114.
4. Auburger, G., Heumann, R., Hellweg, R., Korsching, S. & Thoenen, H. (1987) Developmental changes of nerve growth factor and its mRNA in the rat hippocampus: comparison with choline acetyltransferase. Dev. Biol., 120, 322-328.
5. Bahk, J.Y., Li, S., Park, M.S. & Kim, M.O. (2002) Dopamine D1 and D2 receptor mRNA up-regulation in the caudate-putamen and nucleus accumbens of rat brains by smoking. Prog. Neuropsychopharmacol. Biol. Psychiatry, 26, 1095-1104.
6. Baldo, B.A., Markou, A. & Koob, G.F. (1999) Increased sensitivity to the locomotor depressant effect of a dopamine receptor antagonist during cocaine withdrawal in the rat. Psychopharmacology (Berl.), 141, 135-144.
7. Bayer, L.E., Brown, A., Mactutus, C.F., Booze, R.M. & Strupp, B.J. (2000) Prenatal cocaine exposure increases sensitivity to the attentional effects of the dopamine D1 agonist SKF81297. J. Neurosci., 20, 8902-8908.
8. Belluardo, N., Mudo, G., Blum, M. & Fuxe, K. (2000) Central nicotinic receptors, neurotrophic factors and neuroprotection. Behav. Brain Res., 113, 21-34.
9. Blum, K., Braverman, E.R., Holder, J.M., Lubar, J.F., Monastra, V.J., Miller David, Lubar, J.O., Chen, T.J.H. & Comings, D.E. (2000) Reward deficicency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J. Psychoactive Drugs, 32, 1-68.
10. Brown, R.W., Gass, J.T. & Kostrzewa, R.M. (2002) Ontogenetic quinpirole treatments produce spatial memory deficits and enhance skilled reaching in adult rats. Pharmacol. Biochem. Behav., 72, 591-600.
11. Brown, R.W., Gonzalez, C.L.R., Whishaw, I.Q. & Kolb, B. (2001) Nicotine improvement of Morris water task performance in fornix-lesioned rats is blocked by mecamylamine. Behav. Brain Res., 119, 185-192.
12. Brown, R.W., Kolb, B. & Gonzalez, C.L.R. (2000) Nicotine improves Morris water task performance in rats given medial frontal cortex lesions. Pharm. Biochem. Behav., 67, 473-478.
13. Carlsson, A., Waters, N., Holm-Waters, S., Tedroff, J., Nilsson, M. & Carlsson, M.L. (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu. Rev. Pharmacol. Toxicol., 41, 237-260.
14. Conner, J.M. & Varon, S. (1997) Develomental profile of NGF immunoreactivity in the rat brain: a possible role of NGF in the establishment of cholinergic terminal fields in the hippocampus and cortex. Dev. Brain Res., 101, 67-79.
15. Cooper, S.J., Rusk, I.N. & Barber, D.J. (1989) Yawning induced by the selective dopamine. D2 agonist N-0437 is blocked by the selective dopamine autoreceptor antagonist (+) -UH. Physiol. Behav., 45, 1263-1266.
16. Day, J.C. & Fibiger, H. (1994) Dopaminergic regulation of septohippocampal cholinergic neurons. J. Neurochem., 63, 2086-2092.
17. Dourish, C.J., Herbert, E.N. & Iversen, S.D. (1989) Blockade of apomorphine-induced yawning in rats by the dopamine autoreceptor antagonist (+) -AJ76. Neuropharmacology, 28, 1423-1425.
18. Dunnett, S.B. & Fibiger, H.C. (1993) Role of forebrain cholinergic systems in learning and memory: relevance to the cognitive deficits of aging and Alzheimer's dementia. Prog. Brain Res., 98, 413-420.
19. Ebendal, T. (1989) NGF in CNS: experimental data and clinical implications. Prog. Growth Factor Res., 1, 143-159.
20. Ebendal, T. (1992) Function, evolution in the NGF family, its receptors. J. Neurosci. Res., 32, 461-470.
21. Feldman, R.S., Meyer, J.S. & Quenzer, L.F. (1998) Principles of Neuropsychopharmacology. Sinauer, Sunderland, MA.
22. Fonnum, F. (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem., 24, 407-409.
23. French, S.J., Humby, T., Horner, C.H., Sofroniew, M.V. & Rattray, M. (1999) Hippocampal neurotrophin and trk receptor mRNA levels are altered by local administration of nicotine, carbachol and pilocarpine. Brain Res. Mol. Brain Res., 67, 124-136.
24. Fusco, M., Vantini, G., Schiavo, N., Zanotti, A., Zanoni, R., Facci, L. & Skaper, S.D. (1993) Ganglioslides and neurotrophic factors in neurodegenerative diseases: from experimental findings to clinical perspectives. Ann. NY Acad. Sci., 695, 314-317.
25. Gonzalez, C.L., Kolb, B. & Whishaw, I.Q. (2000) A cautionary note regarding drug and brain lesion studies that use swimming pool tasks: partial reinforcement impairs acquisition of place learning in a swimming pool but not on dry land. Behav. Brain Res., 112, 43-52.
26. Hartikka, J. & Hefti, F. (1988) Comparison of nerve growth factor's effects on development of septum, striatum, and nucleus basalis cholinergic neurons in vitro. J. Neurosci. Res., 21, 352-364.
27. Jeyasingham, R.A., Baird, A.L., Meldrum, A. & Dunnett, S.B. (2001) Differential effects of unilateral striatal and nigrostriatal lesions on grip strength, skilled paw reaching and drug-induced rotation in the rat. Brain Res. Bull., 55, 541-548.
28. Jonnala, R.R. & Buccafusco, J. (2001) Relationship between the increased cell surface alpha7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J. Neurosci. Res., 66, 565-572.
29. Joyce, J.N. (1993) The dopamine hypothesis of schizophrenia: limbic interactions with serotonin and norepinephrine. Psychopharmacology, 112, S16-S34.
30. Joyce, J.N., Goldsmith, S.G. & Gurevich, E.V. (1997) Limbic circuits and monoamine receptors: dissecting the effects of antipsychotics from disease processes. J. Psychiatr. Res., 31, 197-217.
31. Kawai, H., Zago, W. & Berg, D.K. (2002) Nicotinic alpha7 receptor clusters on hippocampal GABAergic neurons: regulation by synaptic activity and neurotrophins. J. Neurosci., 22, 7903-7912.
32. Kenny, P.J., File, S.E. & Rattray, M. (2000) Acute nicotine decreases, and chronic nicotine increases the expression of brain-derived neurotrophic factor mRNA in rat hippocampus. Brain Res. Mol. Brain Res., 85, 234-238.
33. Knusel, B., Rabin, S.J., Hefti, F. & Kaplan, D.R. (1994) Regulated neurotrophin receptor responsiveness during neuronal migration and early differentiation. J. Neurosci., 14, 1542-1554.
34. Kostrzewa, R.M. (1995) Dopamine receptor supersensitivity. Neurosci. Biobehav. Rev., 19, 1-21.
35. Kostrzewa, R.M., Brus, R., Rykaczewska, M. & Plech, A. (1993b) Low-dose quinpirole ontogenically sensitizes to quinpirole-induced yawning in rats. Pharmacol. Biochem. Behav., 44, 487-489.
36. Kostrzewa, R.M., Guo, J. & Kostrzewa, F.P. (1993a) Ontogenetic quinpirole treatement induces vertical jumping activity in rats. Eur. J. Pharmacol., 239. 41-58.
37. Leonard, S., Breese, C., Adams, C., Benhammou, K., Gault, J., Stevens, K., Lee, M., Adler, L., Olincy, A., Ross, R. & Freedman, R. (2000) Smoking and schizophrenia: abnormal nicotinic receptor expression. Eur. J. Pharmacol., 393, 237-242.
38. Levin, E.D. & Simon, B. (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berlin), 138, 217-230.
39. Loschmann, P.A., De Groote, C., Albrecht, C., Darstein, M., Deransart, C., Landwehrmeyer, G.B., Lucking, C.H. & Feuerstein, T.J. (2001) [3H]acetycholine release in rat striatal slices is not subject to dopamine heteroreceptor supersensitivity 30 months after 6-hydroxydopamine lesion of the substantia nigra. Naunyn Schmiedebergs Arch. Pharmacol., 363, 414-421.
40. Magarinos, A.M. & McEwen, B.S. (1995a) Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: comparison of stressors. Neuroscience, 69, 83-88.
41. Magarinos, A.M. & McEwen, B.S. (1995b) Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience, 69, 89-98.
42. Mao, A., Freeman, K.A. & Tallarida, R.J. (1996) Transient loss of dopamine autoreceptor control in the presence of highly potent dopamine agonists. Life Sci., 59, PL317-PL324.
43. Metz, G.A. & Whishaw, I.Q. (2002) Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance. Neuroscience, 111, 325-336.
44. Mottola, D.M., Kilts, J.D., Lewis, M.M., Connery, H.S., Walker, Q.D., Jones, S.R., Booth, R.G., Hyslop, D.K., Piercey, M., Wightman, R.M., Lawler, C.P., Nichols, D.E. & Mailman, R.B. (2002) Functional selectivity of dopamine receptor agonists. I. Selective activation of postsynaptic dopamine D2 receptors linked to adenylate cyclase. J. Pharmacol. Exp. Ther., 301, 1166-1178.
45. Nava, F., Carta, G., Battasi, A.M. & Cessa, G.L. (2000) D (2) dopamine receptors enable delta (9) -tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration. Br. J. Pharmacol., 130, 1201-1210.
46. Neisewander, J.L., Lucki, I. & McGonigle, P. (1996) Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats. Pharmacol. Biochem. Behav., 53, 935-942.
47. Nowak, P., Brus, R. & Kostrzewa, R.M. (2001) Amphetamine-induced enhancement of neostriatal in vivo microdialysate dopamine content in rats, quinpirole-primed as neonates. Pol. J. Pharmacol., 53, 319-329.
48. Ojika, K., Mitake, S., Tohdoh, N., Appel, S.H., Otsuka, Y., Katada, E., Matsukawa, N. (2000) Hippocampal cholinergic neurostimulating peptides (HCNP). Prog. Neurobiol., 60, 37-83.
49. Perry, E., Walker, M., Grace, J. & Perry, R. (1999) Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci., 22, 273-280.
50. Pisani, A., Bonsi, P., Centonze, D., Calabresi, P. & Bernardi, G. (2000) Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J. Neurosci., 20, RC69.
51. Purcell, D.W., Lewine, R.R., Caudel, J. & Price, L.R. (1998) Sex differences in verbal IQ-performance IQ discrepancies among patients with schizophrenia and normal volunteers. J. Abnorm. Psychol., 107, 161-165.
52. Rattray, M. (2001) Is there nicotinic modulation of nerve growth factor? Implications for cholinergic therapies in Alzheimer's disease. Biol. Psychiatry, 49, 185-193.
53. Singer, H.S., Szymanski, S., Giuliano, J., Yokoi, F., Dogan, A.S., Brasic, J.K., Zhou, Y., Grace, A.A. & Wong, D.F. (2002) Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am. J. Psychiatry, 159, 1329-1336.
54. Tzschentke, T.M. & Schmidt, W.J. (2000) Functional relationship among medial prefrontal cortex, nucleus accumbens, and ventral tegmental area in locomotion and reward. Crit. Rev. Neurobiol., 14, 131-142.
55. Ujike, H. (2002) Stimulant-induced psychosis and schizophrenia: the role of sensitization. Curr. Psychiatry Rep., 4, 177-184.
56. Whishaw, I.Q. (1996) An endpoint, descriptive, and kinematic comparison of skilled reaching in mice (Mus musculus) with rats (Rattus norvegicus). Behav. Brain Res., 78, 101-111.
57. Whishaw, I.Q., Gorny, B. & Sarna, J. (1998) Paw and limb use in skilled and spontaneous reaching after pyramidal tract, red nucleus and combined lesions in the rat: behavioral and anatomical dissociations. Behav. Brain Res., 93, 167-183.
58. Whishaw, I.Q. & Metz, G.A.S. (2000) Skilled reaching an action pattern stability in rat (Rattus norvegicus) grasping movements as a function of changing food pellet size. Behav. Brain Res., 116, 111-112.
59. Whishaw, I.Q., Pellis, S.M. & Pellis, V.C. (1992) A behavioral study of the contributions of cells and fibers of passage in the red nucleus of the rat to postural righting, skilled movements, and learning. Behav. Brain Res., 52, 29-44.
60. Whittemore, S.R. & Seiger, A. (1987). The expression, localization and functional significance of beta-nerve growth factor in the central nervous system. Brain Res., 434, 439-464.
61. Woolf, N.J., Milov, A.M., Schweitzer, E.S. & Roghani, A. (2001) Elevation of nerve growth factor and antisense knockdown of Trk A receptor during contextual memory consolidation. J. Neurosci., 21, 1047-1055.
62. Yamada, K. & Furukawa, T. (1980) Direct evidence for involvement of dopaminergic inhibition and cholinergic activation in yawning. Psychopharmacology, 67, 39-43.